Covid vaccine programs could end with third dose, Israeli doctor says

An Israeli nurse receives a fourth dose of the Pfizer-BioNTech COVID-19 coronavirus vaccine at the Sheba Medical Center in Ramat Gan near Tel Aviv, on December 27, 2021. Jack Guez | AFP | Getty Images...

Johnson & Johnson splitting itself up could come with some risks

Johnson & Johnson announced in November that it plans to spin off its consumer business into a new publicly traded company by November 2023. The news didn’t surprise Wall Street. “The ...

Biogen’s Alzheimer’s Drug Aduhelm Has Another Shot at Success

Illustration by Elias Stein Text size Biogen ’s Alzheimer’s disease therapy, Aduhelm, has been a disappointment for the company since its Food and Drug Administration approval last spring, with early ...

Nearly 8% of the S&P 500 has taken a bath this week — 39 stocks fell at least 10%

This stock market is very sensitive to any hint of an increase in interest rates, so it may be no surprise that many tech high-flyers have been falling to earth. But there are others whose shareholder...

5 Companies That Began 2022 With Upbeat News on Dividends

Royalty Pharma, Life Storage, and Viatris, among other companies, rang in 2022 by announcing dividend increases this week. Royalty Pharma (ticker: RPRX) declared a quarterly dividend of 19 cents a sha...

Biotech Stocks Are Due to Bounce Back. This One Stands Out.

Text size Large-cap biotech will offer a smoother ride than small, and Vertex, in particular, looks attractive. Igor Akimov/Dreamstime.com Biotech stocks began the year in much the same way they ended...

Tilray expected to grow sales sequentially but remain in the red

Tilray Inc. will likely grow its sales over the previous quarter but it’s expected to post a net loss when it becomes the first major cannabis company to post quarterly results in 2022 on Monday. Tilr...

New Covid variants are a danger until the whole world is vaccinated

People wearing protective face masks wait to receive a vaccine for the coronavirus disease (COVID-19) at a vaccination centre in Mumbai, India, April 26, 2021. Niharika Kulkarni | Reuters LONDON — New...

Which countries are on track to meet the WHO Covid vaccination target?

A health worker prepares Pfizer vaccine boosters for clients on December 01, 2021 in Sydney, Australia. Lisa Maree Williams | Getty Images The U.S. is among the countries projected to miss the WHOR...

20 cheap value stocks that Wall Street expects to rise up to 58%

There are plenty of arguments for why the bull market for U.S. stocks will continue in 2022. But investors’ focus appears to have shifted recently in favor of value stocks, rather than the growth stoc...

Why Biogen’s Alzheimer’s drug Aduhelm is so controversial

The U.S. Food and Drug Administration’s approval of Biogen’s Alzheimer’s drug Aduhelm in June was heralded as a historic triumph in the fight against a disease that kills thousands o...

23 dividend stocks that can pass this strict quality screen

Stocks are expensive. You’ve probably been hearing that for years, and based on traditional price-to-earnings ratios it’s true. If you invest now in a broad index, such as the benchmark S&P 500 SP...

Moderna Shipped 800 Million Covid-19 Vaccine Doses in 2021

Text size Syringes with Moderna’s Covid-19 vaccine. Thomas Lohnes/Getty Images Moderna said in a letter to shareholders on Tuesday that it had shipped approximately 800 million doses of its Covi...

These 12 ‘Dividend Aristocrat’ stocks have been the best income compounders over 5 years

Stock-market investors typically want to anticipate industry events or companies’ successes so they can make as much money as possible. But as a new year begins, a look back can be useful, especially ...

Johnson & Johnson Is One of Our Stock Picks for 2022

Text size Mark Ralston/AFP via Getty Images This article is an excerpt from Barron’s 10 favorite stocks for 2022, published on Dec. 17. To see the full list, click here. Johnson & Johnson is shaki...

These are the best-performing S&P 500 and Nasdaq-100 stocks of 2021

The performance of the stock market in 2021 has been nothing short of remarkable, surprising many investors after the dramatic crash-and-recovery cycle of 2020. A continuing recovery for the world eco...